Your browser doesn't support javascript.
loading
Chimeric antigen receptor T cells derived from CD7 nanobody exhibit robust antitumor potential against CD7-positive malignancies.
Chen, Dan; You, Fengtao; Xiang, Shufen; Wang, Yinyan; Li, Yafen; Meng, Huimin; An, Gangli; Zhang, Tingting; Li, Zixuan; Jiang, Licui; Wu, Hai; Sheng, Binjie; Zhang, Bozhen; Yang, Lin.
Afiliação
  • Chen D; Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University Suzhou, Jiangsu, China.
  • You F; PersonGen BioTherapeutics (Suzhou) Co., Ltd. Suzhou, Jiangsu, China.
  • Xiang S; PersonGen BioTherapeutics (Suzhou) Co., Ltd. Suzhou, Jiangsu, China.
  • Wang Y; PersonGen BioTherapeutics (Suzhou) Co., Ltd. Suzhou, Jiangsu, China.
  • Li Y; PersonGen BioTherapeutics (Suzhou) Co., Ltd. Suzhou, Jiangsu, China.
  • Meng H; Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University Suzhou, Jiangsu, China.
  • An G; Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University Suzhou, Jiangsu, China.
  • Zhang T; Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University Suzhou, Jiangsu, China.
  • Li Z; Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University Suzhou, Jiangsu, China.
  • Jiang L; Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University Suzhou, Jiangsu, China.
  • Wu H; Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University Suzhou, Jiangsu, China.
  • Sheng B; Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University Suzhou, Jiangsu, China.
  • Zhang B; PersonGen BioTherapeutics (Suzhou) Co., Ltd. Suzhou, Jiangsu, China.
  • Yang L; PersonGen-Anke Cellular Therapeutics Co., Ltd. Hefei, Anhui, China.
Am J Cancer Res ; 11(11): 5263-5281, 2021.
Article em En | MEDLINE | ID: mdl-34873460
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China